The import to Filament’s Metro Vancouver facility was conducted in collaboration with the Peruvian government and facilitated by Filament Health and Jaguar Health VANCOUVER, BC, Sept. 21, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or “Filament Health”), a clinical-stage natural psychedelic drug development company, today announced that Magdalena Biosciences…

Source

Previous articleBridging Dimensions: Understanding the Mystical Experience
Next articleTranscend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD